Washington University School of Medicine: COVID-19 trials

The registry lists 22 COVID-19 studies with Washington University School of Medicine as lead sponsor. 1 are open to participants now and 12 have results posted.

Phase 1 3Phase 2 9Phase 3 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2RecruitingNCT06848309
• Stellate Ganglion Block for COVID-induced ParosmiaCompletedNCT06253806Phase 2Results posted
• Smell in COVID-19 and Efficacy of Nasal Theophylline (SCENT 3)CompletedNCT05947643Phase 2Results posted
• Stellate Ganglion Block for COVID-19-Induced Olfactory DysfunctionCompletedNCT05445921Phase 1/2Results posted
• COVID-19 Vaccine Uptake TrialCompletedNCT05419232Not applicableResults posted
• Efficacy of Gabapentin for Post-Covid-19 Olfactory DysfunctionCompletedNCT05184192Phase 2Results posted
• Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved PopulationCompletedNCT04875520Not applicableResults posted
• Smell in Covid-19 and Efficacy of Nasal TheophyllineCompletedNCT04789499Phase 2Results posted
• Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)CompletedNCT04668950Phase 3Results posted
• Supporting the Health and Well-being of Children With Intellectual and Developmental Disability During COVID-19 PandemicCompletedNCT04565509Not applicableResults posted
• Duvelisib to Combat COVID-19CompletedNCT04372602Phase 2Results posted
• A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 InfectionCompletedNCT04342663Phase 2Results posted
• CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTIONCompletedNCT04333732Phase 3Results posted
• Mindfulness-Based Stress Reduction Versus Lifestyle Intervention for Long-Haul Covid-19 ParosmiaTerminatedNCT06789952Not applicable
• Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated DysomsiaWithdrawnNCT05542095Phase 1
• Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 ParosmiaWithdrawnNCT05216614Phase 2
• Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19CompletedNCT04718220Not applicable
• Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of SmellCompletedNCT04710394Not applicable
• Biomarkers of Trained Immunity Following MMR VaccinationCompletedNCT04646239
• Evaluating the Effect of NT-I7, a Long Acting Interleukin-7, to Increase Lymphocyte Counts and Enhance Immune Clearance of SARS-CoV-2 (COVID-19)WithdrawnNCT04498325Phase 1
• Core Warming of COVID-19 PatientsWithdrawnNCT04426344Not applicable
• Ruxolitinib to Combat COVID-19WithdrawnNCT04354714Phase 2